Graham Taylor has previously received funding from Cancer Research UK, Blood Cancer UK, the UK Medical Research Council, Melanoma UK, and the University of Birmingham to support his research team.

Nearly all adults carry Epstein–Barr virus—but new research reveals how it can hijack immune cells, sparking a chronic disease that attacks the body from within. This colorized transmission electron ...

Scientists have found the clearest evidence yet that Epstein-Barr virus (EBV) – which nearly all of us carry for life – is directly responsible for hijacking our immune system's cells to cause lupus, ...

Kathleen Ford of Solano County was a nurse for more than 20 years, until one day she squatted down to help a patient and, hobbled by terrible joint pain, couldn’t stand up. Then in her 60s, Ford had ...

One of the most common viruses in the world could be the cause of lupus, an autoimmune disease with wide-ranging symptoms, according to a study published Wednesday. Until now, lupus was somewhat ...

For years scientists have suspected that the Epstein-Barr virus (EBV)—a type of herpesvirus that infects 94 percent of the global population by adulthood and causes mononucleosis (aka “mono”)—might be ...

The virus behind glandular fever, also known as mononucleosis or kissing disease, seems to infect and reprogram immune cells in the body, priming some people to develop the autoimmune condition lupus.

With the lupus treatment landscape poised for a shake-up, Roche is hitting the scene in the U.S. with a new green light for its long-approved blood cancer medicine Gazyva. Early Monday, Roche’s ...

The FDA approved Genentech’s CD20-targeting antibody obinutuzumab (Gazyva) for the treatment of adult patients with lupus nephritis who are receiving standard therapy. Obinutuzumab is just the third ...

Source: Getty Images Half of patients with SLE report using complementary and alternative therapies. Lupus nephritis (LN) remains one of the most challenging complications of systemic lupus ...